Telos Capital Management Inc. Acquires 1,879 Shares of Danaher Corporation $DHR

Telos Capital Management Inc. raised its holdings in shares of Danaher Corporation (NYSE:DHR) by 4.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund owned 47,160 shares of the conglomerate’s stock after acquiring an additional 1,879 shares during the period. Telos Capital Management Inc.’s holdings in Danaher were worth $9,316,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in DHR. Sierra Ocean LLC increased its position in shares of Danaher by 116.9% in the 1st quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after buying an additional 76 shares in the last quarter. Red Tortoise LLC increased its position in shares of Danaher by 175.0% in the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after buying an additional 98 shares in the last quarter. Ramirez Asset Management Inc. bought a new stake in shares of Danaher in the 2nd quarter valued at $40,000. Costello Asset Management INC bought a new stake in shares of Danaher in the 1st quarter valued at $41,000. Finally, Mowery & Schoenfeld Wealth Management LLC increased its position in shares of Danaher by 53.8% in the 1st quarter. Mowery & Schoenfeld Wealth Management LLC now owns 203 shares of the conglomerate’s stock valued at $42,000 after buying an additional 71 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of NYSE DHR opened at $215.63 on Monday. The stock has a market capitalization of $152.31 billion, a price-to-earnings ratio of 44.46, a PEG ratio of 3.28 and a beta of 0.77. The business has a 50-day moving average of $203.41 and a 200-day moving average of $199.60. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $258.23.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s revenue for the quarter was up 4.4% compared to the same quarter last year. During the same quarter last year, the company earned $1.71 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, October 31st. Stockholders of record on Friday, September 26th were issued a $0.32 dividend. The ex-dividend date was Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 26.39%.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of recent analyst reports. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research report on Sunday. Barclays lifted their price target on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a research note on Wednesday, October 22nd. Redburn Partners set a $220.00 price target on Danaher in a research note on Wednesday, October 8th. Rothschild Redb downgraded Danaher from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 8th. Finally, Rothschild & Co Redburn reissued a “neutral” rating and issued a $220.00 price target (down previously from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Eighteen research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $243.39.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.